Health ❯ Healthcare

Endocrinology

Hormones Diabetes Management Hormonal Disorders Hormonal Treatments Thyroid Disorders Diabetes Insulin Therapy Weight Management Insulin Management Hypothyroidism

4 ARTICLES

3d ago

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

The move pauses development of a once‑daily GLP‑1/GIP dual agonist after a 16‑week trial showed A1C reductions, meaningful weight loss, and lower insulin needs.

4 ARTICLES

3d ago

Large Observational Studies Link GLP‑1 Drugs to Lower Cancer Rates and Slower Progression

5 ARTICLES

4w ago

Repurposed Kidney Drug Triggers Egg Development in Small POI Trial, Science Study Reports

3 ARTICLES

4mo ago

Kidney Drug Finerenone Shows Early Promise in Restoring Egg Development in Early Menopause

5 ARTICLES

5mo ago

FDA Issues Complete Response Letter for Corcept’s Relacorilant in Cushing’s-Related Hypertension

12 ARTICLES

6mo ago

GLP-1 Boom Hits a Crossroads as States Cut Coverage and Next‑Gen Drugs Advance

3 ARTICLES

6mo ago

10-Minute UCL Scan Pinpoints Source of Aldosterone Excess in Hypertension

4 ARTICLES

6mo ago

Persistent Maternal Thyroid Imbalance in Pregnancy Linked to Higher Autism Risk

4 ARTICLES

6mo ago

Stopping GLP-1 Weight-Loss Drugs Before Pregnancy Linked to Higher Gestational Risks, Study Finds

3 ARTICLES

6mo ago

Testosterone ‘Optimisation’ Boom Draws Medical Warnings on Testing and Fertility Risks

3 ARTICLES

8mo ago

Doctor Warns of Bedroom Symptoms That Can Signal Diabetes

4 ARTICLES

8mo ago

Low-Dose Transplant Drug Preserves Beta Cells in Young People With Type 1 Diabetes, Phase 2 Trial Finds

3 ARTICLES

9mo ago

Phase 3 Trial Shows Baxdrostat Lowers Blood Pressure by About 10 mmHg in Hard-to-Control Hypertension

5 ARTICLES

10mo ago

Glipizide Linked to 13% Higher Cardiovascular Risk Than DPP-4 Inhibitors

3 ARTICLES

10mo ago

Intermittent Energy Restriction Shows Greatest Benefits in Diabetes Weight-Loss Trial

5 ARTICLES

10mo ago

GLP-1 Weight-Loss Drugs Linked to Testosterone Normalization in Men

4 ARTICLES

11mo ago

AstraZeneca’s Baxdrostat Delivers Significant Blood Pressure Reductions in Phase 3 Trial for Resistant Hypertension

Endocrinology

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

Large Observational Studies Link GLP‑1 Drugs to Lower Cancer Rates and Slower Progression

Brazilian Health Bodies Warn on 'Beauty Chip' Implants as Loophole Fuels Use

FDA Grants Accelerated Approval to Lilly’s Oral Weight-Loss Pill Foundayo

Plastic Surgeons Urge Delay of Youth Gender Surgeries as AMA Signals Support

Repurposed Kidney Drug Triggers Egg Development in Small POI Trial, Science Study Reports

Kidney Drug Finerenone Shows Early Promise in Restoring Egg Development in Early Menopause

FDA Issues Complete Response Letter for Corcept’s Relacorilant in Cushing’s-Related Hypertension

GLP-1 Boom Hits a Crossroads as States Cut Coverage and Next‑Gen Drugs Advance

10-Minute UCL Scan Pinpoints Source of Aldosterone Excess in Hypertension

Never miss stories about

Endocrinology

Persistent Maternal Thyroid Imbalance in Pregnancy Linked to Higher Autism Risk

Stopping GLP-1 Weight-Loss Drugs Before Pregnancy Linked to Higher Gestational Risks, Study Finds

Testosterone ‘Optimisation’ Boom Draws Medical Warnings on Testing and Fertility Risks

Doctor Warns of Bedroom Symptoms That Can Signal Diabetes

Low-Dose Transplant Drug Preserves Beta Cells in Young People With Type 1 Diabetes, Phase 2 Trial Finds

Phase 3 Trial Shows Baxdrostat Lowers Blood Pressure by About 10 mmHg in Hard-to-Control Hypertension

Glipizide Linked to 13% Higher Cardiovascular Risk Than DPP-4 Inhibitors

Intermittent Energy Restriction Shows Greatest Benefits in Diabetes Weight-Loss Trial

GLP-1 Weight-Loss Drugs Linked to Testosterone Normalization in Men

AstraZeneca’s Baxdrostat Delivers Significant Blood Pressure Reductions in Phase 3 Trial for Resistant Hypertension

Never miss stories about

Endocrinology